BitcoinWorld

Crypto News Press Release

Injective and Bittensor Hold on for Price Recovery While Milei Moneda Rips Through the Roof With Presale Hype

Injective (INJ) online financial trading chart on crypto currency platform. Ankara, Turkey – April 28, 2023.

TLDR 

  • Injective (INJ) experiences price fluctuations after its inEVM protocol launch.
  • Bittensor’s (TAO) price rally stalls post-Dynamic TAO upgrade. 
  • Milei Moneda’s ($MEDA) presale hype and unique features stun investors and aim for a $0.020 launch.

In recent weeks, several altcoins have experienced notable price fluctuations, with Injective (INJ) and Bittensor (TAO) taking the front seat. However, as both INJ and TAO show potential for price recovery, a newcomer, Milei Moneda ($MEDA), storms into the scene with presale hype. Let’s dive into the details of these tokens below. 

Economize Like Milei: Invest in $MEDA!

 

Injective Launches inEVM: Potential Price Recovery for INJ? 

On March 7, Injective (INJ) launched its inEVM protocol on the mainnet, marking a significant milestone in its integration with the Ethereum ecosystem. This follows a successful testnet implementation and is positioned as a groundbreaking move towards achieving true composability across Cosmos and Solana.

The launch was expected to significantly boost Injective’s (INJ) price performance. However, following the launch, the altcoin price experienced notable fluctuations, raising concerns amongst investors. 

The launch of the inEVM protocol signifies Injective’s (INJ) dedication to innovation and its commitment to addressing the needs of the developer community. As the protocol gains traction within the Ethereum ecosystem, hopes are high for a potential price recovery as crypto enthusiasts watch Injective (INJ) navigate the blockchain space. 

 

Crypto News: Bittensor (TAO) Rally Stalls After Dynamic TAO Pump, Will the Upgrade Deliver Long-Term Growth?

Just like Injective (INJ), Bittensor (TAO) has already seen notable price fluctuations in recent weeks. This comes after the altcoin experienced a significant price increase in February, nearly reaching a $3 billion crypto market cap. 

Bittensor’s (TAO) February price rally is attributed to its Dynamic TAO upgrade. The upgrade represents a significant change to Bittensor’s tokenomics, aiming to streamline token distribution within the network. News of the upgrade initially pumped Bittensor’s (TAO) price, but as the frenzy died down, the altcoin’s price rally also reduced.

Despite the altcoin’s current price struggles, price projections signal an incoming price recovery. The Dynamic TAO upgrade has the potential to increase efficiency, incentivize subnet growth, and attract new users to Bittensor’s network. Experts say this could translate to long-term growth for TAO.

 

New Meme Coin Milei Moneda ($MEDA) Takes DeFi by Storm

As Injective’s (INJ) and Bittensor’s (TAO) enthusiasts await a price recovery for both altcoins, the crypto market is experiencing the emergence of a new DeFi coin, Milei Moneda ($MEDA). Milei Moneda ($MEDA) is making waves as a true meme coin, blending humor, politics, and blockchain technology in homage to the rebellious spirit of President Javier Milei. 

Positioned as one of the top DeFi projects in 2024, Milei Moneda advocates for economic reforms and financial independence, offering unique features such as deflationary tokens, NFTs, and governance through its native token, $MEDA. These features have significantly drawn attention to the DeFi coin’s ongoing presale. 

Investors are eagerly anticipating the official launch of $MEDA on May 21 on Uniswap, where it will trade at $0.020, reflecting a 100% increase from its current Stage 1 presale price of $0.010. This exciting profit potential has sparked widespread interest, with $MEDA topping the list of altcoins to watch out for! 

Got $MEDA curiosity? Visit us or chat on Telegram for the inside scoop. Fast, fun, and informative!

Disclaimer: The information provided is not trading advice, Bitcoinworld.co.in holds no liability for any investments made based on the information provided on this page. We strongly recommend independent research and/or consultation with a qualified professional before making any investment decisions.